Do you have the same question? Follow this Question
Jul 10, 2025 - 01:45 PM
We’ve provided several answers to questions related to Binosto (Alendronate Sodium) , see some other helpful Q&A related to this product.
Question: What is the active ingredient in Binosto?
Answer: The active ingredient in Binosto is alendronate sodium. This active component is responsible for inhibiting bone resorption, helping to increase bone density and reduce the risk of fractures.
Question: What is the KEGG identifier for Binosto?
Answer: The KEGG identifier for Binosto is D07119. KEGG provides information on the drug's metabolic pathways and interactions, which is useful for researchers and clinicians in understanding its pharmacological effects.
Question: What is the ATC code for Binosto?
Answer: The ATC code for Binosto is M05BA04. The Anatomical Therapeutic Chemical (ATC) classification system provides a way to categorize the drug based on its therapeutic use, helping in its systematic classification and study.
Question: What is the PubChem CID for Binosto?
Answer: The PubChem CID for Binosto is 2088. This unique identifier allows researchers and healthcare professionals to access detailed chemical information about the drug, supporting informed decision-making.
Question: What is the protein binding percentage for Binosto?
Answer: The protein binding of Binosto is 78%. This high protein binding affects how the drug is distributed in the body, influencing its duration of action and interaction with other medications.
Question: Is Binosto recommended during pregnancy?
Answer: Binosto is not recommended for use during pregnancy. This caution is crucial as it prioritizes the safety of both the mother and the developing fetus, given the lack of established safety data in pregnant populations.
Question: What is the elimination half-life of Binosto?
Answer: The elimination half-life of Binosto is 126 months. This extended half-life indicates that the drug remains in the body for a long time, allowing for less frequent dosing and sustained therapeutic effects.
Question: What is the chemical name for Binosto?
Answer: The chemical name for Binosto is Alendronic acid. Knowing the chemical name helps healthcare professionals understand the active component responsible for the drug's therapeutic effects.
Question: What licenses does Binosto have?
Answer: Binosto is licensed by the US FDA (Food and Drug Administration) and the EU EMA (European Medicines Agency). These licenses indicate that the product meets rigorous safety and efficacy standards, providing reassurance to consumers about its quality and effectiveness.
